BNA Q&A: Grant Bogle, executive vice president, US Oncology


  • Print
  • Connect
  • Email
  • Facebook
  • Twitter
  • LinkedIn
  • Google+

US Oncology, a cancer treatment and research company, is working with Milliman to develop new risk-contracting methodologies and models that will help physician-led oncology organizations improve care quality while reducing healthcare costs. US Oncology Executive Vice President Grant Bogle discusses the risk-contracting project in this Q&A with the Bureau of National Affairs' Medicare Report.